Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZS-003: Zirconium Silicate in Hyperkalemia
NCT01737697Phase 3Completed
- Sponsor
- ZS Pharma
- Start
- Nov 2012
- Primary completion
- Oct 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 3 trial of sodium zirconium cyclosilicate in hyperkalemia, sponsored by ZS Pharma. Started Nov 2012; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT01737697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01737697.